Yan Qin

Associate, New York

Biography

Overview

Yan is an associate in the Mergers & Acquisitions Practice Group, and is based in the New York office. Yan focuses her practice on domestic and cross-border mergers and acquisitions, private investments, joint ventures and general corporate matters in a wide range of industries.

Prior to joining White & Case, Yan was a senior associate in the New York office of a major Chinese law firm, advising private and public clients on cross-border M&A deals, joint ventures, venture capital transactions and De-SPAC transactions.

Bars and Courts
New York State Bar
Education
JD
Fordham University School of Law
LLM
Yale Law School
LLB
Jilin University
Languages
English
Mandarin

Experience

Recent transactions include the:

  • Representation of Saudi Aramco in its entry into an Equity Purchase Agreement with US-based automotive services provider Valvoline, Inc., to acquire Valvoline, Inc.'s Global Products Business for US$2.65 billion, subject to certain customary adjustments.
  • Representation of a group of funds in their equity investment in connection with financing the acquisition of TransUnion's healthcare business by nThrive, Inc., sponsored by Clearlake Capital.

Her experience prior to joining White & Case includes the:

  • Representation of Scienjoy Inc. in its business combination with Wealthbridge Acquisition Limited, a NASDAQ-listed SPAC.
  • Representation of Joinn Laboratories (China) Co. Ltd. (HKEX: 06127) in its acquisition of Biomedical Research Models, Inc., a Massachusetts-based pre-clinical CRO.
  • Representation of Tsingshan Group in connection with its establishment of an innovative 50-50 joint venture with Allegheny Technologies Incorporated (NYSE: ATI), to reopen a stainless steel DRAP finishing facility in Western Pennsylvania.
  • Representation of Zhejiang Semir Garment Co. (SZ: 002563) in its equity investment in JWU LLC, a New York-based fashion company involving the leading designer brand Jason Wu.
  • Representation of Caissa Sega Tourism Culture Development Group Co., Ltd. in its US$65 million acquisition of a 21.1% stake in Tuniu Corporation (NASDAQ: TOUR) from subsidiaries of JD.com, Inc. (NASDAQ: JD).
  • Representation of Thalys Medical Technology Group Corp (SH: 603716) in its equity investment in LevitasBio, a life science technology company using novel platform magnetic levitation technology.